BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2013
View Archived Issues
KaloBios Pharmaceuticals prepares novel monoclonal antibodies for COPD
Read More
FDA grants second fast track designation for MABp1
Read More
Data from genome-wide association study in patients with anemia published
Read More
Computational integration of schizophrenia-related genomics uncovers functional gene networks
Read More
Novel candidate antidiabetic drugs patented by Ajinomoto
Read More
Roche presents new TaR-1 ligands
Read More
Novel HIV vaccine adjuvants created by French investigators
Read More
Arena Pharmaceuticals prepares new GPR119 receptor ligands
Read More
Researchers study novel PRMT5 inhibitors for the treatment of beta-thalassemia and SCD
Read More
FDA grants QIDP designation to Paratek Pharmaceuticals' omadacycline
Read More
FDA clears IND for TGR-1202 studies
Read More
Kyowa Hakko Kirin advances second oncology candidate under agreement with Dicerna
Read More
Immunovaccine reports preclinical data on DepoVax-based anthrax vaccines
Read More
Investigators develop mouse model for evaluation of anti-human CD37 therapeutics
Read More
Philogen enters into worldwide licensing agreement with Pfizer for Dekavil
Read More
Savant obtains NIDA funding for preclinical development of 18-MC
Read More
Development of a low-cost, large-scale, multiplex-targeted, candidate gene mutation screen
Read More
FDA clears IND to investigate OrbeShield in GI-ARS
Read More
Receptos commences patient dosing in phase II trial of RPC-1063 in ulcerative colitis
Read More
Phase II trial of RM-493 for treatment of obesity begins
Read More
Data suggest 12-mg Proellex-V dose optimal for uterine fibroid treatment
Read More
Proteon Therapeutics reports results from study of recombinant human elastase
Read More
Bayer files application in Japan for use of VEGF TrapEye in macular edema following CRVO
Read More
iCo Therapeutics provides update on phase II iCo-007 trial
Read More
Biogen Idec files BLA for long-lasting factor IX therapy for hemophilia B
Read More